|

Fluoropyrimidine Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • Memorial Sloan Kettering Cancer Center1

Indications

  • Cancer2
  • Advanced Esophageal Cancer1
  • Systemic Scleroderma1
  • Systemic Lupus Erythematosus1
  • Sjogren Syndrome1

Birmingham, Alabama1 trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of Alabama at Birmingham Cancer Center

Phase 1

Basking Ridge, New Jersey1 trial

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Memorial Sloan Kettering at Basking Ridge (Limited protocol activities)

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.